Citations

Clear

15 citation(s) found for "Sciallis, GF".

Is Gianotti–Crosti Syndrome Associated with Atopy? A Case–Control Study and a Postulation on the Intrinsic Host Factors in Gianotti–Crosti Syndrome
Chuh, Antonio , Zawar, Vijay , Sciallis, Gabriel F., Sciallis, Gabriel, Lee, Albert

Mayo Clinic

Pediatric Dermatology | June 25, 2016 | Volume: 33 | Issue: 5 | Pages: 488-492

10.1111/pde.12886 | PMID 27339179 Get It

AbstractObjectivesTo investigate whether Gianotti–Crosti syndrome (GCS) in children is associated with atopy.MethodsThe setting was two outpatient clinic. Diagnoses of asthma and atopic dermatitis (AD) were made according to internationally accepted diagnostic criteria. Allergic rhinitis, atopic urticaria, and allergic conjunctivitis were diagnosed clinically. Participants were children with GCS diagnosed over the previous 5 years. For any child with GCS, we extracted the record of the subsequent age and sex pair‐matched child seen for problems unrelated to the skin as controls.ResultsWe retrieved the records of 37 pairs of study and control subjects; 28 (76%) children with GCS and 9 (24%) controls had AD (risk ratio [RR] = 3.11[95% confidence interval {CI} 1.73, 5.73]), 31 (84%) children with GCS and 19 (51%) controls had at least one atopic condition (RR = 1.63 [95% CI 1.13, 2.18]) and 11 (30%) children with GCS and 2 (5%) controls had at least three atopic conditions (RR = 5.50 [95% CI 1.29, 35.35]).ConclusionGCS is significantly associated with AD and the presence of atopic conditions.
Lenalidomide treatment of cutaneous lupus erythematosus: the Mayo Clinic experience
Kindle, Scott A., Wetter, David A. , Davis, Mark D.P. , Pittelkow, Mark R. , Sciallis, Gabriel F.

Mayo Clinic

International Journal of Dermatology | February 13, 2016 | Volume: 55 | Issue: 8 | Pages: No page available

10.1111/ijd.13226 | PMID 26873674 Get It

AbstractBackgroundPublished case series describe lenalidomide as an effective treatment of refractory cutaneous lupus erythematosus (CLE).ObjectivesThe present study aimed to further characterize lenalidomide use in the treatment of CLE.MethodsA retrospective review of patients treated with lenalidomide for CLE from January 1, 2000, to December 17, 2014, was conducted.ResultsEight of the nine patients (89%) were women. Their median age at initiation of lenalidomide was 62 years (range: 41–86 years). Subtypes of CLE included discoid lupus erythematosus (DLE) (n = 6), lupus panniculitis (n = 2), and subacute CLE (n = 1). Before the initiation of lenalidomide, all patients had been previously treated unsuccessfully or were intolerant to at least one antimalarial and one immunosuppressive agent. With lenalidomide, five patients achieved a complete response (CR), two a partial response, and two had no response (lupus panniculitis). Time to initial response (dose range: 2.5–10.0 mg/d) varied from 2 weeks to 3 months; the median time to CR in five patients was 3 months (range: 3–6 months). The median duration of lenalidomide therapy was 12 months (range: 2–67 months). The median duration of follow‐up was 48 months (range: 20–103 months). Adverse effects included mild leukopenia; one patient had deep vein thrombosis of unclear etiology during a hospitalization. No patients developed or showed progression of systemic LE while receiving lenalidomide.ConclusionsLenalidomide was effective for the treatment of CLE (particularly DLE) but not for the treatment of lupus panniculitis in this series.
Endoscopic Ultrasound Fine-Needle Aspiration Cytology Mutation Profiling Using Targeted Next-Generation Sequencing
Gleeson, Ferga C. , Kipp, Benjamin R. , Voss, Jesse S. , Campion, Michael B., Minot, Douglas M., Tu, Zheng Jin, Klee, Eric W. , Sciallis, Andrew P. , Graham, Rondell P. , Henry, Michael , Levy, Michael J., Lazaridis, Konstantinos N. , Levy, Michael J. , Graham, Rondell P

Mayo Clinic

American Journal of Clinical Pathology | May 13, 2015 | Volume: 143 | Issue: 6 | Pages: 879-888

10.1309/ajcpu3j7fgayqbrl | PMID 25972331 Get It

An investigation into false‐negative transthoracic fine needle aspiration and core biopsy specimens
Minot, Douglas M., Gilman, Elizabeth A. , Aubry, Marie‐Christine, Voss, Jesse S. , Epps, Sarah G. Van, Tuve, Delores J, Sciallis, Andrew P. , Henry, Michael , Salomão, Diva R. , Carlson, Stephanie K., Clayton, Amy C., Aubry, Marie-Christine, Lee, Peter

Mayo Clinic

Diagnostic Cytopathology | May 28, 2014 | Volume: 42 | Issue: 12 | Pages: 1063-1068

10.1002/dc.23169 | PMID 24866385 Get It

Transthoracic fine needle aspiration (TFNA)/core needle biopsy (CNB) under computed tomography (CT) guidance has proved useful in the assessment of pulmonary nodules. We sought to determine the TFNA false‐negative (FN) rate at our institution and identify potential causes of FN diagnoses. Medical records were reviewed from 1,043 consecutive patients who underwent CT‐guided TFNA with or without CNB of lung nodules over a 5‐year time period (2003–2007). Thirty‐seven FN cases of “negative” TFNA/CNB with malignant outcome were identified with 36 cases available for review, of which 35 had a corresponding CNB. Cases were reviewed independently (blinded to original diagnosis) by three pathologists with 15 age‐ and sex‐matched positive and negative controls. Diagnosis (i.e., nondiagnostic, negative or positive for malignancy, atypical or suspicious) and qualitative assessments were recorded. Consensus diagnosis was suspicious or positive in 10 (28%) of 36 TFNA cases and suspicious in 1 (3%) of 35 CNB cases, indicating potential interpretive errors. Of the 11 interpretive errors (including both suspicious and positive cases), 8 were adenocarcinomas, 1 squamous cell carcinoma, 1 metastatic renal cell carcinoma, and 1 lymphoma. The remaining 25 FN cases (69.4%) were considered sampling errors and consisted of 7 adenocarcinomas, 3 nonsmall cell carcinomas, 3 lymphomas, 2 squamous cell carcinomas, and 2 renal cell carcinomas. Interpretive and sampling error cases were more likely to abut the pleura, while histopathologically, they tended to be necrotic and air‐dried. The overall FN rate in this patient cohort is 3.5% (1.1% interpretive and 2.4% sampling errors). Diagn. Cytopathol. 2014;42:1063–1068;. © 2014 Wiley Periodicals, Inc.
Clinicopathologic Predictors of Thyroid Bed Recurrence of Differentiated Thyroid Cancer Using Ultrasound-Guided Fine-Needle Aspiration Biopsies
Adhikari, Laura , Sciallis, Andrew P. , Reynolds, Jordan , Jenkins, Sarah M. , Smith, Carin Y. , Stan, Marius N. , Nassar, Aziza , Nassar, Aziza , Smith, Carin Y , Stan, Marius N , Reynolds, Jordan P

Mayo Clinic

Thyroid | February 1, 2013 | Volume: 23 | Issue: 8 | Pages: 982-988

10.1089/thy.2012.0297 | PMID 23374006 Get It